(This is the third and final part of our series on Mesothelioma Clinical Trials.)
Phase III clinical trials typically enroll a large number of patients. These studies are often done in many different locations at the same time. They are likely tobe
Read the full story
Phase 0 mesothelioma clinical trials are designed to determine if and how a new mesothelioma drug might work in a human. Mesothelioma patients are currently not eligible to enroll in phase 0 studies, but they may be in the near future. Read the full story
A study published in the newest Proceedings of the National Academy of Sciences medical journal has found that at least 12 states contain deposits of an asbestos-like fiber than may cause mesothelioma and has been ravaging villages in Turkey for years now.
Focusing primarily onDunn
Read the full story
The University of Hawai’i Cancer Center has received a generous gift of more than $3 million to continue its important research regarding the causes of mesothelioma as well as potential cure for the disease.
An anonymous donor has given a $3.58 million donation to the Hawaiicancer
Read the full story
Doctors at the 1st International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica, CA have unanimously decided against using radical lung removal procedures to treat patients who are suffering from malignant pleural mesothelioma.
Experts and physicians at the symposium analyzed datagathered
Read the full story